Evaluate the Safety and Clinical Activity of HH2853

NCT04390737 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

254

Enrollment

INDUSTRY

Sponsor class

Conditions

FL Lymphoma
Epithelioid Sarcoma
Peripheral T Cell Lymphoma
Advanced Solid Tumor

Interventions

DRUG: HH2853 Tablets

Sponsor

Haihe Biopharma Co., Ltd.